Background: Infliximab (IFX) treatment induces mucosal healing (MH) in patients with Crohn's disease (CD) but the impact of MH on the long-term outcome of IFX treatment in CD is still debated. ## Methods: We studied MH during long-term treatment with IFX in 214 CD patients. A total of 183 patients
(039) Does mucosal healing with corticosteroids could change short and long term outcome of Crohn’s disease patients?
✍ Scribed by N. Bounab; M. Nakmouche; N. Kaddache; L. Kecili; A. Balamane; N. Debzi; K. Belhocine; K. Layaida; N. Baiod; T. Boucekkine
- Book ID
- 119184146
- Publisher
- Elsevier
- Year
- 2009
- Tongue
- English
- Weight
- 47 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1687-1979
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background: Although a mainstay of treatment of moderate to severe Crohn's disease (CD), corticosteroids use presents significant challenges because of large interindividual variability in response. Corticosteroid-dependence is of particular concern in children, where high rates have been reported.
## Background: Long-term enteral nutrition may maintain clinical and endoscopic remission in patients with crohn's disease (cd). the aim of this prospective study was to investigate the impacts of long-term enteral nutrition on clinical and endoscopic disease activities and mucosal tissue cytokines